Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities
Multiple sclerosis (MS) remains one of the most important complex neurological disorders affecting young adults, and its unpredictable onset creates a major challenge for prevention, diagnosis, and long-term care. The article “Predicting Multiple Sclerosis: Challenges and Opportunities” by Hone, Giovannoni, Dobson, and Jacobs examines whether genetic and environmental information can be combined to estimate an individual’s future risk of developing MS. The authors argue that prediction is scientifically plausible in principle, but clinically difficult in practice because MS is uncommon, biologically complex, and shaped by many small genetic and environmental effects rather than a single dominant cause.
Genetic Architecture and Polygenic Risk
A central theme of the article is that MS is a highly polygenic disease. More than 200 genetic loci have been associated with susceptibility, with the strongest known signal located in the HLA region, particularly the HLA-DRB1*15:01 allele. However, even this major risk allele is insufficient to predict disease on its own. Instead, modern approaches use polygenic risk scores, which aggregate the effects of many genetic variants across the genome. These scores can distinguish MS cases from controls at a population level, but their individual predictive value remains limited because each variant usually contributes only a small increase in risk.
Environmental Risk Factors and Their Integration
The authors also emphasize that environmental exposures are essential components of MS susceptibility. Factors such as low vitamin D status, Epstein–Barr virus infection or infectious mononucleosis, smoking, and childhood or adolescent obesity have been repeatedly associated with increased MS risk. In theory, combining these exposures with genetic risk scores should improve prediction. In practice, environmental risk scoring is complicated because exposures are often difficult to measure accurately, may vary across the life course, and may interact with genetic background. A simple binary record of whether someone has smoked or had infectious mononucleosis may fail to capture the biological timing and intensity of risk.
Why Current Prediction Models Fall Short
Although several studies have tested genetic and combined genetic-environmental models for MS prediction, their performance has generally been modest. Many report area-under-the-curve values that suggest some ability to separate cases from controls, but these metrics can be misleading. A model may perform reasonably well statistically while still being poor as a clinical test for individuals. Because MS has a low population prevalence, even a model with high sensitivity and specificity may identify many more false positives than true positives. This severely limits the positive predictive value of MS risk prediction in general populations.
Methodological and Biological Barriers
The article identifies several technical obstacles that restrict the accuracy of current models. Polygenic risk scores often rely on common variants discovered in genome-wide association studies, but they may miss rare variants, causal variants hidden by linkage disequilibrium, and gene–gene or gene–environment interactions. Another major limitation is ancestry: most MS genetic studies have been conducted in populations of European ancestry, making prediction less reliable for individuals from other ancestral backgrounds. The authors also note that some MS risk may arise from stochastic biological processes, such as random immune events, which would be inherently difficult to incorporate into deterministic prediction models.
Opportunities for Prevention Research
Despite these limitations, the article presents a cautiously optimistic perspective. The most promising use of MS risk scores may not be routine clinical prediction for individuals, but risk enrichment for preventive trials. Preventive interventions require very large study populations when the disease is rare. If researchers can identify groups with substantially elevated risk, trials of preventive strategies—such as interventions targeting Epstein–Barr virus, vitamin D insufficiency, or obesity-related pathways—could become more feasible. In this context, risk scores may serve as research tools rather than diagnostic instruments.
A Realistic Future for MS Prediction
The article ultimately argues for a balanced view of MS prediction. Genetic and environmental risk scores are valuable for understanding disease biology and designing future prevention studies, but they are unlikely to provide definitive individual-level forecasts in the near future. Future progress will depend on larger and more diverse genomic datasets, improved measurement of environmental exposures, better modeling of gene–environment interactions, and careful communication of uncertainty to patients and clinicians. The central message is that MS prediction is not a failed concept, but its most realistic value lies in population stratification, prevention research, and deeper biological insight rather than precise personal forecasting.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Jacobs, B. M., Noyce, A., Bestwick, J., Belete, D., Giovannoni, G., & Dobson, R. (2020). Gene-environment interactions in Multiple Sclerosis: a UK Biobank study. bioRxiv, 2020-03.
